These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1907256)

  • 21. Apoptosis in tumor necrosis factor-alpha-dependent, monocyte-mediated leukemic cell death: a functional, morphologic, and flow-cytometric analysis.
    van de Loosdrecht AA; Ossenkoppele GJ; Beelen RH; Broekhoven MG; Dräger AM; Langenhuijsen MM
    Exp Hematol; 1993 Dec; 21(13):1628-39. PubMed ID: 8243565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
    Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
    Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma.
    Jun CD; Yoon HJ; Kim HM; Chung HT
    Biochem Biophys Res Commun; 1995 Jan; 206(3):969-74. PubMed ID: 7832812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of the strength of cell-cell adhesion: the capture of tumor cells by activated murine macrophages proceeds through two distinct stages.
    Somers SD; Whisnant CC; Adams DO
    J Immunol; 1986 Feb; 136(4):1490-6. PubMed ID: 3080524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visualization of the uptake and processing of oxidized low-density lipoproteins in human and rat liver.
    Esbach S; Pieters MN; van der Boom J; Schouten D; van der Heyde MN; Roholl PJ; Brouwer A; van Berkel TJ; Knook DL
    Hepatology; 1993 Sep; 18(3):537-45. PubMed ID: 8359796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitors of C1q biosynthesis suppress activation of murine macrophages for both antibody-independent and antibody-dependent tumor cytotoxicity.
    Leu RW; Zhou AQ; Shannon BJ; Herriott MJ
    J Immunol; 1990 Mar; 144(6):2281-6. PubMed ID: 2107257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophages kill T9 glioma tumor cells bearing the membrane isoform of macrophage colony stimulating factor through a phagocytosis-dependent pathway.
    Jadus MR; Williams CC; Avina MD; Ly M; Kim S; Liu Y; Narasaki R; Lowell CA; Wepsic HT
    J Immunol; 1998 Jan; 160(1):361-8. PubMed ID: 9551992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The binding of BCG-activated macrophages to tumor targets stimulates secretion of cytolytic factor.
    Johnson WJ; Whisnant CC; Adams DO
    J Immunol; 1981 Nov; 127(5):1787-92. PubMed ID: 6795261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predisposition of [125I]5-iodo-2'-deoxyuridine-labeled normal and neoplastic mouse fibroblasts to lysis by normal macrophages.
    Evans R; Eidlen DM
    J Natl Cancer Inst; 1983 Nov; 71(5):983-9. PubMed ID: 6580500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of tumor necrosis factor in macrophage activation and tumoricidal activity.
    Mace KF; Ehrke MJ; Hori K; Maccubbin DL; Mihich E
    Cancer Res; 1988 Oct; 48(19):5427-32. PubMed ID: 3416299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients.
    Gordon IO; Freedman RS
    Clin Cancer Res; 2006 Mar; 12(5):1515-24. PubMed ID: 16533776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.
    Fernandez-Cruz E; Ulich T; Schreiber RD
    J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines.
    Ralph P; Nakoinz I
    Cancer Res; 1981 Sep; 41(9 Pt 1):3546-50. PubMed ID: 6973392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B cell lymphoma-2 transfected P815 cells resist reactive nitrogen intermediate-mediated macrophage-dependent cytotoxicity.
    Albina JE; Martin BA; Henry WL; Louis CA; Reichner JS
    J Immunol; 1996 Jul; 157(1):279-83. PubMed ID: 8683126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human monocyte-mediated antibody dependent cytotoxicity to K-562 cells: an electron microscopic study.
    Espevik T; Hammerstrøm J
    Acta Pathol Microbiol Immunol Scand C; 1983 Jun; 91(3):211-9. PubMed ID: 6880752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of selective tumor cell binding by activated murine macrophages in response to phorbol myristate acetate.
    Somers SD; Adams DO
    J Immunol; 1986 Mar; 136(6):2323-32. PubMed ID: 3512713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms.
    Cui S; Reichner JS; Mateo RB; Albina JE
    Cancer Res; 1994 May; 54(9):2462-7. PubMed ID: 8162595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of macrophage tumoricidal activity by photodynamic treatment in vitro--indirect activation of macrophages by photodynamically killed tumor cells.
    Reiter I; Schwamberger G; Krammer B
    J Photochem Photobiol B; 1999 Jun; 50(2-3):99-107. PubMed ID: 10515075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of membrane-associated TNF in the killing of Leishmania donovani parasites by macrophages.
    Lohmann-Matthes ML; Lüttig B; Hockertz S
    Behring Inst Mitt; 1991 Feb; (88):125-32. PubMed ID: 2049029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of transmethylation reactions in regulating the binding of BCG-activated murine macrophages to neoplastic target cells.
    Adams DO; Pike MC; Snyderman R
    J Immunol; 1981 Jul; 127(1):225-30. PubMed ID: 7240742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.